Adults who had a lower respiratory tract infection such as bronchitis or pneumonia before the age of 2 may be at higher risk of dying prematurely from respiratory disease, according to a new study.
Children who contract lower respiratory tract infection (LRTI) at two years of age or younger could be more likely to die prematurely from that same condition as adults, a new study has found. These ...
Please provide your email address to receive an email when new articles are posted on . Lower respiratory tract infection by age 2 years increased premature death risk from a respiratory cause in ...
The study included 31,900 infants, 49.1% of whom received nirsevimab. HealthDay News — Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower ...
On Friday, the U.S. Food and Drug Administration (FDA) expanded the approved age indication for GSK plc’s GSK respiratory ...
ENFLONSIA is a preventive monoclonal antibody designed to protect infants against a spectrum of RSV disease severity, including worsening disease requiring hospitalization ENFLONSIA is the first and ...
Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection and hospitalization in infants. Nirsevimab is a monoclonal antibody to the RSV fusion protein that has an ...
Ronald Dijkman, Institute for Infectious Diseases (IFIK), University of Bern For example, SARS-CoV infection is characterized by severe disease and inflammation in the lower respiratory tract and ...
Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV prefusion F glycoprotein, is under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results